News and commentary from the endocrinology world ...

For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to ...

Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...

Rapid advances in artificial intelligence (AI), computational medicine, and digital health are fundamentally reshaping respiratory and critical care ...

A doctor and patient both offer their perspectives on the challenges of returning home from the hospital after a COPD ...

Treatment options for managing your PH will depend on what type of pulmonary hypertension you have. Each type of pulmonary hypertension requires a tailored treatment plan that follows the latest ...

Clinical Question: Can d-dimers rule out pulmonary embolisms when not “within normal limits?” Background: D-dimer tests are frequently ordered at low clinical thresholds, but values not “within normal ...

This section describes the evidence gaps, why they need to be addressed and their relative importance for future committee decision making. The committee will not be able to make a positive ...

Table 1 summarises the evidence gaps and ongoing studies that might address them. Information about evidence status is derived from the external assessment report. More information on the studies in ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

Background Severe exacerbation of chronic obstructive pulmonary disease (COPD) is a trajectory-changing life event for patients and a major contributor to health system costs. This study evaluates the ...

Credit: Getty Images The 2026 GOLD COPD Update provides updated guidance on case-finding, disease activity, exacerbation management, and AI, as well as new criteria GOLD categories. The Global ...